NLRP3 and sarcopenia: Different signals can lead to the activation of the NLRP3 inflammasome and cause sarcopenia; for example, metabolic dysregulation due not only to obesity but also to insulin resistance [43] leads to hyperglycemia and muscle atrophy via the WWP1/KLF15 pathway [44].